[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351869-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351869-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","il-1cxcl12-signalling-orchestrates-adipocytepancreatic-neuroendocrine-tumor-crosstalk","IL-1β/CXCL12 signalling orchestrates adipocyte–pancreatic neuroendocrine tumor crosstalk","","Pancreatic neuroendocrine tumors (PanNETs) are rare, yet visceral obesity correlates with higher incidence and worse clinicopathological outcomes. The mechanisms of adipocyte–PanNET interaction remain unclear. Using indirect co-culture systems and conditioned media from differentiated 3T3–L1 adipocytes or PanNET cells (BON-1, QGP-1), the study identifies PanNET-driven conversion of adipocytes into cancer-associated adipocytes mediated by IL-1β and linked to CXCL12 secretion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/il-1cxcl12-signalling-orchestrates-adipocytepancreatic-neuroendocrine-tumor-crosstalk/351869/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/il-1cxcl12-signalling-orchestrates-adipocytepancreatic-neuroendocrine-tumor-crosstalk/351869.png","ImageObject",300,407,{"name":42,"@type":43},"4398046744996","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study model interactions between adipocytes and PanNET cells?","Question",{"text":63,"@type":64},"It used indirect co-culture systems and conditioned media from differentiated 3T3–L1 adipocytes or from PanNET cells (BON-1 and QGP-1).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What adipocyte changes were driven by PanNET cells?",{"text":68,"@type":64},"PanNET cells induced a cancer-associated adipocyte phenotype with lipid depletion and reduced adipogenic markers such as Pparg, Fabp4, Hsl, and Atgl.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do IL-1β and CXCL12 play in the proposed signalling axis?",{"text":72,"@type":64},"PanNET-derived IL-1β drives adipocyte conversion into cancer-associated adipocytes, which secrete CXCL12; this promotes PanNET proliferation and IL-1β release, forming a positive bidirectional feedback-like loop.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351869,1790386561,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":11,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":138,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},4398046744996,"Oldani etal. Journal of Translational Medicine (2026) 24:807  \n[https://doi.org/10.1186/s12967-026-08428-z](https://doi.org/10.1186/s12967-026-08428-z)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nIL-1β/CXCL12 signalling orchestratesadipocyte–pancreatic neuroendocrine tumor crosstalk  \nMonica Oldani1, Elisa Stellaria Grassi2, Germano Gaudenzi1, Ilona Rybinska3, Silvia Carra2, Elena Massardi1, Nicola Fazio4, Michele Caraglia5,6, Luca Persani2,3 and Giovanni Vitale1,3*  \nAbstract  \nBackground Pancreatic neuroendocrine tumors (PanNETs) are rare neoplasms belonging to the broader group of neuroendocrine neoplasms. Epidemiological evidence indicates that visceral obesity is associated with both an increased incidence of PanNETs and unfavorable clinicopathological features. However, the mechanisms underlying adipocyte–PanNETs interactions remain poorly understood.  \nMethods Here, we investigated the crosstalk between adipocytes and PanNET cells (BON-1 and QGP-1 cell lines) using indirect co-culture systems and conditioned media derived from differentiated 3T3–L1 adipocytes or PanNET cells.  \nResults Our results demonstrate that PanNET cells induce adipocyte reprogramming toward a cancer-associated adipocyte (CAA) phenotype, characterized by lipid depletion and downregulation of adipogenic markers, including Pparg, Fabp4, Hsl, and Atgl. We identified PanNET-derived interleukin-1β (IL-1β) as a key driver of adipocyte conversion into CAAs. This process was accompanied by increased secretion ofthe chemokine CXCL12 from CAAs, which in turn appeared to enhance PanNET cell proliferation and IL-1β release, thereby establishing a positive bidirectional crosstalk consistent with a feedback-like mechanism between CXCL12 and IL-1β in CAAs and PanNET cells, respectively. Indeed, pharmacological disruption of this axis using AMD3100, a CXCR4 antagonist, significantly reduced both IL-1β and CXCL12 secretion, prevented adipocyte reprogramming, and suppressed tumor cell proliferation. Comparable effects were observed following incubation of PanNET–adipocyte co-cultures with canakinumab, an IL-1β pathway inhibitor. Conclusion Collectively, these findings identify IL-1β and CXCL12 as potential critical mediators ofthe inflammatory crosstalk between adipocytes and PanNET cells. Targeting this signalling axis may therefore represent a promising therapeutic strategy for PanNETs.  \nKeywords Pancreatic neuroendocrine tumors, Adipocyte–tumor crosstalk, Cancer-associated adipocytes, IL-1β, CXCL12/CXCR4 axis  \n*Correspondence: Giovanni Vitale  \ng.vitale@auxologico.it  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nOldani et al. Journal of Translational Medicine (2026) 24:807 Page 2 of 22  \nGraphical Abstract  \nIntroduction  \nPancreatic neuroendocrine tumors (PanNETs) are rare neoplasms, accounting for less than 3% of all primary pancreatic malignancies [1–3]. Although PanNETs are often considered indolent, their biological and clinical behavior is highly heterogene","cbCaistnvyT3rMN3","https://ap.wps.com/l/cbCaistnvyT3rMN3","pdf",8394979,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## PanNET heterogeneity and treatment limitations\n## Obesity, fatty pancreas, and rationale for adipocyte involvement","[{\"question\":\"How did the study model interactions between adipocytes and PanNET cells?\",\"answer\":\"It used indirect co-culture systems and conditioned media from differentiated 3T3–L1 adipocytes or from PanNET cells (BON-1 and QGP-1).\"},{\"question\":\"What adipocyte changes were driven by PanNET cells?\",\"answer\":\"PanNET cells induced a cancer-associated adipocyte phenotype with lipid depletion and reduced adipogenic markers such as Pparg, Fabp4, Hsl, and Atgl.\"},{\"question\":\"What role do IL-1β and CXCL12 play in the proposed signalling axis?\",\"answer\":\"PanNET-derived IL-1β drives adipocyte conversion into cancer-associated adipocytes, which secrete CXCL12; this promotes PanNET proliferation and IL-1β release, forming a positive bidirectional feedback-like loop.\"}]","IL-1β/CXCL12 signalling orchestrates adipocyte–pancreatic neuroendocrine tumor crosstalk | PDF",1790096362,55,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12138f5a89bde291f3d8239552e7222d.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55e83d3bddfc00cea1c8868fbb569793.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/011d03dcae04d91278c08e6368f0343f.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d9aa822a5b9b38f04c991c34ee89461.webp",980,1306]